INOVIO PHARMACEUTICALS, INC. Number of Operating Segments
INOVIO PHARMACEUTICALS, INC. (INO) reported Number of Operating Segments of 1 segment for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Notes
us-gaap:NumberOfOperatingSegments · last filed 2024-03-06
- INOVIO PHARMACEUTICALS, INC. number of operating segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. number of operating segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
- INOVIO PHARMACEUTICALS, INC. number of operating segments for fiscal 2021 was 1.00 segment, a 0.00% change from fiscal 2020.
- INOVIO PHARMACEUTICALS, INC. number of operating segments for fiscal 2020 was 1.00 segment, a 0.00% change from fiscal 2019.
| Period end | Number of Operating Segments 12 month |
|---|---|
| 2023-12-31 | 1.00 segment 10-K · filed 2024-03-06 |
| 2022-12-31 | 1.00 segment 10-K · filed 2023-03-01 |
| 2021-12-31 | 1.00 segment 10-K · filed 2022-03-01 |
| 2020-12-31 | 1.00 segment 10-K · filed 2021-03-01 |
| 2019-12-31 | 1.00 segment 10-K · filed 2020-03-12 |
| 2018-12-31 | 1.00 segment 10-K · filed 2019-03-12 |
| 2017-12-31 | 1.00 segment 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |